
Glial expression of cannabinoid CB2 receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome
Keywords: cannabinoids; inflammation; amyloid; immunohistochemistry; AA; arachidonic acid; Aβ; β-amyloid; AD; Alzheimer's disease; AEA; arachidonoylethanolamide (anandamide); DS; Down's syndrome; ECS; endocannabinoid system; FAAH; fatty acid amide hydrolase;